Naporafenib : ARAF recurrent mutation causes central conducting lymphatic anomaly treatable with a MEK inhibitor
Smad Signal
The main signal transducers for receptors of the TGF-B
Naporafenib : ARAF recurrent mutation causes central conducting lymphatic anomaly treatable with a MEK inhibitor